BANK OF AMERICA CORP /DE/ - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 88 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2017. The put-call ratio across all filers is 18.43 and the average weighting 0.3%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2022$39354
+137.6%
0.00%
Q3 2022$0149
+223.9%
0.00%
Q2 2022$046
-27.0%
0.00%
Q1 2022$063
-91.1%
0.00%
Q4 2021$0
-100.0%
711
-99.9%
0.00%
Q3 2021$666,000
+404.5%
653,407
+806.4%
0.00%
Q2 2021$132,000
-9.6%
72,088
-2.8%
0.00%
Q1 2021$146,000
+231.8%
74,190
+108.1%
0.00%
Q4 2020$44,000
-88.0%
35,652
-82.6%
0.00%
Q3 2020$368,000
+12.5%
204,671
+425.6%
0.00%
Q2 2020$327,000
+217.5%
38,940
+99.1%
0.00%
Q1 2020$103,000
+4.0%
19,558
+7.8%
0.00%
Q4 2019$99,000
-21.4%
18,141
-29.9%
0.00%
Q3 2019$126,000
-32.6%
25,887
-4.2%
0.00%
Q2 2019$187,000
-66.1%
27,031
-66.0%
0.00%
Q1 2019$552,000
+153.2%
79,474
+113.0%
0.00%
Q4 2018$218,000
-17.4%
37,304
+6.7%
0.00%
Q3 2018$264,000
+380.0%
34,969
+222.1%
0.00%
Q2 2018$55,000
-33.7%
10,855
-19.7%
0.00%
Q1 2018$83,000
-23.9%
13,520
-12.1%
0.00%
Q4 2017$109,000
+419.0%
15,378
+436.0%
0.00%
Q3 2017$21,000
+425.0%
2,869
+309.9%
0.00%
Q2 2017$4,000
-42.9%
700
-30.0%
0.00%
Q3 2016$7,0001,000
+49900.0%
0.00%
Q2 2016$020.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q4 2017
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$1,273,0000.73%
ETF MANAGERS GROUP, LLC 7,062,485$1,787,0000.05%
Ikarian Capital, LLC 862,527$217,0000.04%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 457,209$115,0000.02%
Platform Technology Partners 33,750$9,0000.01%
PINNACLE ASSOCIATES LTD 910,006$230,0000.01%
CJM Wealth Advisers, Ltd. 30,465$7,6830.01%
Mirae Asset Global Investments Co., Ltd. 4,029,171$1,016,0000.00%
Vident Investment Advisory, LLC 267,612$67,0000.00%
Aries Wealth Management 15,400$4,0000.00%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders